ProMIS Neurosciences
Dr. Alain Dagher, MD, FRCP (C) has been an attending neurologist at the Montreal Neurological Institute, McGill University, since 1997, specializing in movement disorders and functional brain imaging. His research has two components: (1) understanding neurodegenerative diseases including Parkinson's disease; (2) identifying the neural mechanisms that support motivated decision-making, with application to addiction and obesity. His lab uses functional brain imaging in human subjects, including anatomical and functional magnetic resonance imaging, positron emission tomography and transcranial magnetic stimulation. His group has recently investigated the topography of neurodegeneration in PD to test propagation models, develop biomarkers, and stratify patients to predict disease outcomes. Research focuses on Parkinson's disease, stress, addiction, and obesity. He has published extensively on brain imaging (200+ publications, >50 on Parkinson’s Disease) and is senior editor of Neuroimage.
This person is not in the org chart
This person is not in any offices
ProMIS Neurosciences
ProMIS™ Neurosciences, Inc. is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).